Suppr超能文献

醋酸纤维素固体分散体提高难溶性药物姜黄素的生物利用度。

Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion.

机构信息

Tianjin Key Laboratory of Modern Drug Delivery and High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, People's Republic of China.

出版信息

AAPS PharmSciTech. 2012 Mar;13(1):159-66. doi: 10.1208/s12249-011-9732-9. Epub 2011 Dec 16.

Abstract

Curcumin (Cur), one of the most widely used natural active constituents with a great variety of beneficial biological and pharmacological activities, is a practically water-insoluble substance with a short biologic half-life. The aim of this study was to develop a sustained-release solid dispersion by employing water-insoluble carrier cellulose acetate for solubility enhancement, release control, and oral bioavailability improvement of Cur. Solid dispersions were characterized by solubility, in vitro drug release, Fourier transform infrared spectroscopy, X-ray diffractometry, and differential scanning calorimetry studies. The in vivo performance was assessed by a pharmacokinetic study. Solid-state characterization techniques revealed the amorphous nature of Cur in solid dispersions. Solubility/dissolution of Cur was enhanced in the formulations in comparison with pure drug. Sustained-release profiles of Cur from the solid dispersions were ideally controlled in vitro up to 12 h. The optimized formulation provided an improved pharmacokinetic parameter (C(max) = 187.03 ng/ml, t(max) = 1.95 h) in rats as compared with pure drug (C(max) = 87.06 ng/ml, t(max) = 0.66 h). The information from this study suggests that the developed solid dispersions successfully enhanced the solubility and sustained release of poorly water-soluble drug Cur, thus improving its oral bioavailability effectively.

摘要

姜黄素(Cur)是最广泛使用的天然活性成分之一,具有多种有益的生物和药理活性,它实际上是一种水溶性差的物质,生物半衰期短。本研究的目的是通过使用不溶性载体醋酸纤维素来开发一种缓释固体分散体,以提高姜黄素的溶解度、控制释放和口服生物利用度。通过溶解度、体外药物释放、傅里叶变换红外光谱、X 射线衍射和差示扫描量热法研究对固体分散体进行了表征。通过药代动力学研究评估了体内性能。固态表征技术表明,姜黄素在固体分散体中呈无定形状态。与纯药物相比,制剂中姜黄素的溶解度/溶解得到了提高。姜黄素从固体分散体中的体外释放呈现出理想的持续释放特征,可达 12 小时。与纯药物(C(max)=87.06ng/ml,t(max)=0.66h)相比,优化的配方在大鼠中提供了改善的药代动力学参数(C(max)=187.03ng/ml,t(max)=1.95h)。这项研究的信息表明,所开发的固体分散体成功地提高了水溶性差的药物姜黄素的溶解度和持续释放,从而有效地提高了其口服生物利用度。

相似文献

1
Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion.
AAPS PharmSciTech. 2012 Mar;13(1):159-66. doi: 10.1208/s12249-011-9732-9. Epub 2011 Dec 16.
3
Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System.
AAPS PharmSciTech. 2015 Dec;16(6):1327-34. doi: 10.1208/s12249-014-0254-0. Epub 2015 Mar 25.
5
Improved Oral Absorption of Poorly Soluble Curcumin via the Concomitant Use of Borneol.
AAPS PharmSciTech. 2019 Mar 22;20(4):150. doi: 10.1208/s12249-019-1364-5.
7
Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Carbohydr Polym. 2013 Oct 15;98(1):1108-16. doi: 10.1016/j.carbpol.2013.07.017. Epub 2013 Jul 16.
10
Preparation, physicochemical and pharmacological study of curcumin solid dispersion with an arabinogalactan complexation agent.
Int J Biol Macromol. 2019 May 1;128:158-166. doi: 10.1016/j.ijbiomac.2019.01.079. Epub 2019 Jan 18.

引用本文的文献

1
Nanocurcumin in myocardial infarction therapy: emerging trends and future directions.
Front Bioeng Biotechnol. 2025 Jan 8;12:1511331. doi: 10.3389/fbioe.2024.1511331. eCollection 2024.
2
Recent Advances in Nano-Drug Delivery Systems for the Treatment of Diabetic Wound Healing.
Int J Nanomedicine. 2023 Mar 27;18:1537-1560. doi: 10.2147/IJN.S395438. eCollection 2023.
3
Next-Generation Hydrogels as Biomaterials for Biomedical Applications: Exploring the Role of Curcumin.
ACS Omega. 2023 Feb 28;8(10):8960-8976. doi: 10.1021/acsomega.2c07062. eCollection 2023 Mar 14.
7
SmartFilm Tablets for Improved Oral Delivery of Poorly Soluble Drugs.
Pharmaceutics. 2022 Sep 10;14(9):1918. doi: 10.3390/pharmaceutics14091918.
10
Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth.
Front Pharmacol. 2022 Apr 14;13:863082. doi: 10.3389/fphar.2022.863082. eCollection 2022.

本文引用的文献

1
beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):113-25. doi: 10.1016/j.colsurfb.2010.03.039. Epub 2010 Apr 3.
2
Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
AAPS PharmSciTech. 2010 Jun;11(2):518-27. doi: 10.1208/s12249-010-9404-1. Epub 2010 Mar 18.
3
Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240.
Eur J Pharm Biopharm. 2010 Feb;74(2):233-8. doi: 10.1016/j.ejpb.2009.10.004. Epub 2009 Oct 25.
5
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Int J Pharm. 2009 Apr 17;371(1-2):148-55. doi: 10.1016/j.ijpharm.2008.12.009. Epub 2008 Dec 13.
6
Improved dissolution of oleanolic acid with ternary solid dispersions.
AAPS PharmSciTech. 2007 Dec 21;8(4):E113. doi: 10.1208/pt0804113.
7
Bioavailability of curcumin: problems and promises.
Mol Pharm. 2007 Nov-Dec;4(6):807-18. doi: 10.1021/mp700113r. Epub 2007 Nov 14.
8
Formulation and characterization of curcuminoids loaded solid lipid nanoparticles.
Int J Pharm. 2007 Jun 7;337(1-2):299-306. doi: 10.1016/j.ijpharm.2006.12.043. Epub 2007 Jan 9.
9
Enhancement of dissolution profile by solid dispersion (kneading) technique.
AAPS PharmSciTech. 2006 Aug 18;7(3):68. doi: 10.1208/pt070368.
10
Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Eur J Pharm Biopharm. 2007 Jan;65(1):26-38. doi: 10.1016/j.ejpb.2006.07.007. Epub 2006 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验